China's Impact on the Future of Drug Delivery and Biologics

China is rapidly evolving from a manufacturing powerhouse to one of the most important sources of biopharma innovation and investment globally. From biologics and antibody-drug conjugates (ADCs) to novel drug delivery technologies and an increasingly sophisticated venture ecosystem, the Chinese biopharma ecosystem is reshaping the competitive landscape and creating new opportunities for partnership, licensing and growth.

This webinar brings together experts from pharma, market intelligence and venture capital to discuss how China's innovation ecosystem is evolving and what it means for drug delivery stakeholders worldwide. Learn where innovation is happening, which technologies are generating the greatest excitement and how global companies are responding.

Key Takeaways

• The evolution of China's biotech ecosystem and innovation capabilities
• Emerging opportunities in biologics, ADCs, peptides, RNA therapeutics and advanced drug delivery systems
• How cross-border licensing and partnering models are changing.
• Key investment themes shaping the next generation of companies.
• Opportunities and risks for drug delivery innovators.